These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15524133

  • 1. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
    Hulstein JJ, Rison CN, Kappers-Klunne MC, Hene RJ, Franx A, de Groot PG, Brand A, Fijnheer R.
    Ned Tijdschr Geneeskd; 2004 Oct 02; 148(40):1972-6. PubMed ID: 15524133
    [Abstract] [Full Text] [Related]

  • 2. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
    Lattuada A, Rossi E, Calzarossa C, Candolfi R, Mannucci PM.
    Haematologica; 2003 Sep 02; 88(9):1029-34. PubMed ID: 12969811
    [Abstract] [Full Text] [Related]

  • 3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun 02; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 4. [A woman suffering from systemic lupus erythematosus and acquired thrombotic thrombocytopenic purpura].
    Verheijen FM, Reedijk L, Fijnheer R.
    Ned Tijdschr Geneeskd; 2004 Oct 02; 148(40):1977-81. PubMed ID: 15524134
    [Abstract] [Full Text] [Related]

  • 5. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
    Rick ME, Austin H, Leitman SF, Krizek DM, Aronson DL.
    Am J Hematol; 2004 Feb 02; 75(2):96-100. PubMed ID: 14755376
    [Abstract] [Full Text] [Related]

  • 6. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
    Studt JD, Kremer Hovinga JA, Alberio L, Bianchi V, Lämmle B.
    Swiss Med Wkly; 2003 Jun 14; 133(23-24):325-32. PubMed ID: 12923683
    [Abstract] [Full Text] [Related]

  • 7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B.
    N Engl J Med; 1998 Nov 26; 339(22):1578-84. PubMed ID: 9828245
    [Abstract] [Full Text] [Related]

  • 8. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F, Ferrari S, Lavoretano S, Canciani MT, Mannucci PM.
    Br J Haematol; 2004 Nov 26; 127(4):433-9. PubMed ID: 15521921
    [Abstract] [Full Text] [Related]

  • 9. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL.
    Semin Hematol; 2004 Jan 26; 41(1):4-14. PubMed ID: 14727254
    [Abstract] [Full Text] [Related]

  • 10. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M.
    Expert Rev Cardiovasc Ther; 2003 Jul 26; 1(2):243-55. PubMed ID: 15030284
    [Abstract] [Full Text] [Related]

  • 11. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M, Betz C, Miesbach W, Krause M, von Auer C, Geiger H, Scharrer I.
    Br J Haematol; 2005 Jun 26; 129(5):644-52. PubMed ID: 15916687
    [Abstract] [Full Text] [Related]

  • 12. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct 26; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 13. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH, van de Kar NC, van den Heuvel LP.
    Ned Tijdschr Geneeskd; 2003 Dec 06; 147(49):2422-4. PubMed ID: 14694551
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.
    Camilleri RS, Cohen H, Mackie IJ, Scully M, Starke RD, Crawley JT, Lane DA, Machin SJ.
    J Thromb Haemost; 2008 Feb 06; 6(2):331-8. PubMed ID: 18031293
    [Abstract] [Full Text] [Related]

  • 15. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases.
    Franchini M, Montagnana M, Targher G, Lippi G.
    Semin Thromb Hemost; 2007 Nov 06; 33(8):787-97. PubMed ID: 18175284
    [Abstract] [Full Text] [Related]

  • 16. Thrombotic thrombocytopenic purpura.
    Lämmle B, Kremer Hovinga JA, Alberio L.
    J Thromb Haemost; 2005 Aug 06; 3(8):1663-75. PubMed ID: 16102032
    [Abstract] [Full Text] [Related]

  • 17. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
    Arai S, Allan C, Streiff M, Hutchins GM, Vogelsang GB, Tsai HM.
    Hematol J; 2001 Aug 06; 2(5):292-9. PubMed ID: 11920264
    [Abstract] [Full Text] [Related]

  • 18. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM.
    J Mol Med (Berl); 2002 Oct 06; 80(10):639-47. PubMed ID: 12395148
    [Abstract] [Full Text] [Related]

  • 19. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL.
    Arch Pathol Lab Med; 2002 Nov 06; 126(11):1430-3. PubMed ID: 12421153
    [Abstract] [Full Text] [Related]

  • 20. Limitations of ADAMTS-13 activity level in diagnosing thrombotic thrombocytopenic purpura in pregnancy.
    Ehsanipoor RM, Rajan P, Holcombe RF, Wing DA.
    Clin Appl Thromb Hemost; 2009 Oct 06; 15(5):585-7. PubMed ID: 19022799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.